Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-22

Clinical Trial Update: I-FALMIN Albumin Supplement for Patients With Pulmonary Tuberculosis [NA]

View source ↗

Summary

Clinical trial update for I-FALMIN albumin supplement in patients with pulmonary tuberculosis and hypoalbuminemia. The study is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • I-FALMIN Albumin Supplement (albumin supplement)

Snippet

Sponsor: Hasanuddin University | Conditions: Pulmonary Tuberculosis, Hypoalbuminemia | NA | Status: ACTIVE_NOT_RECRUITING